News
Recent news about Panacea Capital and select portfolio companies
April 17, 2026
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell and Gene Therapy
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell…
April 17, 2026
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell and Gene Therapy
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell…
April 17, 2026
From China, Bridging Biopharmaceutical Innovation in Korea - Chime Biologics Empowers a New Landscape for Korea's Biopharma Industry
April 17, 2026
From China, Bridging Biopharmaceutical Innovation in Korea - Chime Biologics Empowers a New Landscape for Korea's Biopharma Industry
April 9, 2026
Kainova Therapeutics Expands Phase I / II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe
April 9, 2026
Kainova Therapeutics Expands Phase I / II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe
April 3, 2026
Winning in Biosimilars: Speed, Scale, and the New Competitive Playbook
April 3, 2026
Winning in Biosimilars: Speed, Scale, and the New Competitive Playbook
March 27, 2026
Chime Biologics Congratulates Hope Medicine Inc. on Successful Dosing of First Patient in Phase III Clinical Trial for Endometriosis in China
March 27, 2026